Scarica l'app Stockscreener
9.42
4.46%
-0.44
Dopo l'orario di chiusura:
9.64
0.22
+2.34%
Precedente Chiudi:
$9.86
Aprire:
$9.86
Volume 24 ore:
551.51K
Relative Volume:
0.70
Capitalizzazione di mercato:
$475.84M
Reddito:
$89.04M
Utile/perdita netta:
$-241.08M
Rapporto P/E:
-1.7909
EPS:
-5.26
Flusso di cassa netto:
$-194.72M
1 W Prestazione:
+4.55%
1M Prestazione:
+13.09%
6M Prestazione:
+59.12%
1 anno Prestazione:
-16.49%
Intervallo 1D:
$9.12
$9.90
Intervallo di 1 settimana:
$8.675
$9.90
Portata 52W:
$5.035
$13.48
Regenxbio Inc Stock (RGNX) Company Profile
Nome
Regenxbio Inc
Settore
Industria
Telefono
240-552-8181
Indirizzo
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD
Confronta RGNX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RGNX
Regenxbio Inc
|
9.42 | 460.69M | 89.04M | -241.08M | -194.72M | -5.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Regenxbio Inc Stock (RGNX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-11 | Downgrade | Goldman | Buy → Neutral |
| 2025-02-07 | Ripresa | Raymond James | Outperform |
| 2024-11-15 | Ripresa | Morgan Stanley | Overweight |
| 2024-10-10 | Ripresa | Raymond James | Outperform |
| 2024-06-07 | Iniziato | Goldman | Buy |
| 2024-03-11 | Iniziato | H.C. Wainwright | Buy |
| 2024-03-08 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-03-06 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-02-21 | Ripresa | Raymond James | Outperform |
| 2023-11-01 | Iniziato | Stifel | Buy |
| 2023-06-02 | Iniziato | Robert W. Baird | Outperform |
| 2022-06-23 | Iniziato | Berenberg | Buy |
| 2021-12-15 | Iniziato | Wedbush | Neutral |
| 2021-10-19 | Ripresa | Morgan Stanley | Overweight |
| 2021-01-06 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2020-12-16 | Iniziato | UBS | Buy |
| 2020-06-25 | Ripresa | BofA/Merrill | Buy |
| 2020-05-13 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-08-20 | Aggiornamento | SVB Leerink | Underperform → Mkt Perform |
| 2019-06-18 | Reiterato | Chardan Capital Markets | Buy |
| 2019-06-14 | Ripresa | Raymond James | Outperform |
| 2019-06-05 | Reiterato | Chardan Capital Markets | Buy |
| 2019-02-25 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-02-05 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-12-17 | Reiterato | Chardan Capital Markets | Buy |
| 2018-11-08 | Reiterato | BofA/Merrill | Neutral |
| 2018-08-08 | Reiterato | Chardan Capital Markets | Buy |
| 2018-07-23 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2018-07-10 | Reiterato | Chardan Capital Markets | Buy |
| 2018-05-09 | Reiterato | Barclays | Overweight |
| 2018-04-09 | Reiterato | Chardan Capital Markets | Buy |
| 2018-03-12 | Downgrade | Evercore ISI | Outperform → In-line |
| 2018-02-13 | Iniziato | Mizuho | Neutral |
| 2017-11-09 | Ripresa | Morgan Stanley | Overweight |
Mostra tutto
Regenxbio Inc Borsa (RGNX) Ultime notizie
Long term hold vs stop loss in REGENXBIO Inc.Watch List & Stepwise Trade Signal Guides - Newser
Multi factor analysis applied to REGENXBIO Inc.Quarterly Earnings Summary & Fast Gain Stock Trading Tips - Newser
Should value investors consider REGENXBIO Inc.July 2025 Technicals & Expert-Curated Trade Recommendations - khodrobank.com
Can machine learning forecast REGENXBIO Inc. recoveryTrade Exit Report & Growth Focused Entry Reports - Newser
News impact scoring models applied to REGENXBIO Inc.Market Growth Review & Consistent Profit Trading Strategies - Newser
Should you wait for a breakout in REGENXBIO Inc.July 2025 Trends & Community Verified Trade Signals - Newser
REGENXBIO Inc. Stocks Attracting Dip Buyers getLinesFromResByArray error: size == 0 - thegnnews.com
Strategies to average down on REGENXBIO Inc.July 2025 Recap & Free Daily Entry Point Trade Alerts - Newser
Risk adjusted return profile for REGENXBIO Inc. analyzedMarket Risk Analysis & Safe Entry Zone Tips - Newser
Will REGENXBIO Inc. bounce back from current supportTrade Exit Summary & Weekly High Potential Stock Alerts - Newser
How to monitor REGENXBIO Inc. with trend dashboardsJuly 2025 Sentiment & Community Trade Idea Sharing - Newser
Will REGENXBIO Inc. stock go up in YEARJuly 2025 Sector Moves & Stepwise Trade Signal Implementation - khodrobank.com
Signal strength of REGENXBIO Inc. stock in tech scannersPortfolio Value Summary & Low Risk High Reward Trade Ideas - Newser
Trend analysis for REGENXBIO Inc. this weekMarket Volume Report & Daily Entry Point Trade Alerts - Newser
Can REGENXBIO Inc. be recession proofJuly 2025 Retail & Weekly High Return Forecasts - khodrobank.com
How institutional ownership impacts REGENXBIO Inc. stockQuarterly Market Summary & Free High Return Stock Watch Alerts - Newser
Applying Wyckoff theory to REGENXBIO Inc. stockM&A Rumor & Pattern Based Trade Signal System - Newser
What high frequency data says about REGENXBIO Inc.Quarterly Trade Summary & Long-Term Safe Return Strategies - Newser
Can REGENXBIO Inc. expand its profit margins2025 Growth vs Value & Free Real-Time Market Sentiment Alerts - khodrobank.com
Has REGENXBIO Inc. found a price floorRisk Management & Free High Accuracy Swing Entry Alerts - Newser
Is this a good reentry point in REGENXBIO Inc.Weekly Stock Summary & Expert Verified Movement Alerts - Newser
Analyzing REGENXBIO Inc. with multi timeframe chartsRisk Management & Weekly Chart Analysis and Trade Guides - Newser
Applying sector rotation models to REGENXBIO Inc.Weekly Gains Summary & Daily Chart Pattern Signals - Newser
Real time pattern detection on REGENXBIO Inc. stock2025 Sector Review & Fast Moving Stock Watchlists - Newser
Top chart patterns to watch in REGENXBIO Inc.Market Growth Report & Reliable Entry Point Trade Alerts - Newser
What is REGENXBIO Inc. s debt to equity ratioJuly 2025 Trade Ideas & AI Forecasted Entry/Exit Points - khodrobank.com
Regenxbio says FDA extends review date for Hunter syndrome drug - MSN
What’s the beta of REGENXBIO Inc. stock2025 Buyback Activity & Precise Trade Entry Recommendations - خودرو بانک
Can REGENXBIO Inc. recover in the next quarter2025 Earnings Surprises & Trade Opportunity Analysis Reports - Newser
Can REGENXBIO Inc. expand into new markets2025 Technical Patterns & Expert Verified Movement Alerts - khodrobank.com
Published on: 2025-09-01 14:14:01 - Newser
Identifying reversal signals in REGENXBIO Inc.July 2025 Opening Moves & Weekly Momentum Stock Picks - Newser
What recovery options are there for REGENXBIO Inc.Market Growth Report & Fast Gain Stock Tips - Newser
REGENXBIO Inc. Recovery Linked to Earnings Surprise getLinesFromResByArray error: size == 0 - kangso.co.kr
Sentiment analysis tools applied to REGENXBIO Inc.Weekly Trade Summary & Safe Entry Momentum Tips - Newser
Trendline Breach Raises Concern for REGENXBIO Inc. Investors2025 Breakouts & Breakdowns & Capital Efficiency Focused Strategies - beatles.ru
Detecting price anomalies in REGENXBIO Inc. with AIJuly 2025 Summary & Low Drawdown Trading Strategies - Newser
Candlestick signals on REGENXBIO Inc. stock todayJuly 2025 Macro Moves & Low Risk High Win Rate Stock Picks - Newser
Institutional Tools Highlight Unusual Flow in REGENXBIO Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Regenxbio Inc Azioni (RGNX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Regenxbio Inc Azioni (RGNX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Mills Kenneth T. | Director |
May 12 '25 |
Sale |
7.91 |
20,602 |
163,046 |
475,103 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):